King Milling


New York

King serves as Managing Partner of the Firm.

King is a partner in the New York office and a member of the Global Mergers & Acquisitions and Private Equity Group. His practice focuses on domestic and cross-border M&A, joint venture, private equity and venture capital transactions, including negotiated mergers, auction bid processes, distressed asset sales, leveraged buyouts and the acquisition and divestiture of divisions and subsidiaries.

King is experienced in all aspects of Delaware and New York corporate, partnership and limited liability company law. He regularly counsels boards of directors on corporate governance, compliance, fiduciary duty and executive compensation matters.

King represents U.S. and non-U.S. clients in a wide range of industries, including life sciences, technology, energy, consumer products, industrials and manufacturing and financial services.

  • King’s recent transactions include representing:

    • Macquarie Infrastructure and Real Assets and Skanska Infrastructure Development in their divestiture of their respective interests in Elizabeth River Crossings (ERC)
    • Macquarie Infrastructure and Real Assets in connection with the auction sale of MIRA’s equity interests in a portfolio of maritime port assets in the U.S. and Canada, including Halterm Container Terminal in Halifax, Canada and Penn Terminals in Eddystone, Pennsylvania
    • Veolia, a global water management, waste management and energy services company, in several transactions, including the $1.25 billion divestiture of its U.S. district energy business
    • Superior Plus Corp. and its affiliates in several transactions, including the $900 million acquisition of the retail propane business of NGL Energy Partners and the $325 million divestiture of its construction products distribution business
    • IFM Investors Pty. Ltd., in its $5.72 billion acquisition of ITR Concession Company, LLC
    • eCORP, a leader in the development and operation of natural gas storage facilities, in various joint venture and infrastructure transactions, including its acquisition of the Gill Ranch natural gas storage facility in California
    • Par Pharmaceutical Companies, Inc., at the time a NYSE-listed developer, manufacturer and marketer of generic drugs, in its $1.9 billion all cash acquisition by the private equity firm TPG.
    • Par Pharmaceutical in its $410 million acquisition of Anchen Pharmaceuticals.
    • Paddock Labs, a privately-held manufacturer and marketer of generic pharmaceutical products, in its $540 million sale to Perrigo Co., a leading global healthcare supplier.
    • CoorsTek, Inc. a leading global manufacturer of technical ceramic and specialty material components, in various transactions, including its $245 million acquisition of the Advanced Ceramics business of Saint-Gobain, a French multinational corporation, as well as in a number of other transactions.